True Wealth Design LLC Increases Stock Position in CME Group Inc. (NASDAQ:CME)

True Wealth Design LLC grew its stake in shares of CME Group Inc. (NASDAQ:CME) by 15.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 668 shares of the financial services provider’s stock after acquiring an additional 89 shares during the period. True Wealth Design LLC’s holdings in CME Group were worth $155,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. SJS Investment Consulting Inc. lifted its holdings in CME Group by 570.6% in the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after buying an additional 97 shares in the last quarter. New Age Alpha Advisors LLC raised its stake in CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 43 shares during the period. Financial Life Planners acquired a new stake in CME Group during the fourth quarter worth about $32,000. Knuff & Co LLC bought a new position in CME Group in the 4th quarter worth about $33,000. Finally, Banque Transatlantique SA bought a new position in shares of CME Group in the fourth quarter valued at approximately $35,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Stock Performance

Shares of CME stock opened at $276.29 on Friday. The firm has a 50-day moving average of $265.86 and a 200-day moving average of $247.18. The company has a market cap of $99.56 billion, a P/E ratio of 28.57, a P/E/G ratio of 6.76 and a beta of 0.45. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. CME Group Inc. has a one year low of $190.70 and a one year high of $286.48.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.61 by $0.19. The business had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The firm’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter last year, the company posted $2.50 earnings per share. Equities research analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be given a dividend of $1.25 per share. The ex-dividend date is Monday, June 9th. This represents a $5.00 annualized dividend and a yield of 1.81%. CME Group’s payout ratio is presently 50.30%.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on CME shares. Piper Sandler raised their price objective on shares of CME Group from $275.00 to $283.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 8th. JPMorgan Chase & Co. dropped their target price on shares of CME Group from $223.00 to $211.00 and set an “underweight” rating on the stock in a report on Thursday, April 24th. Keefe, Bruyette & Woods boosted their price objective on shares of CME Group from $265.00 to $273.00 and gave the stock a “market perform” rating in a report on Thursday, April 24th. Bank of America lifted their target price on shares of CME Group from $200.00 to $219.00 and gave the company an “underperform” rating in a research report on Wednesday, April 2nd. Finally, UBS Group boosted their price target on shares of CME Group from $290.00 to $305.00 and gave the company a “buy” rating in a research report on Friday, April 25th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $256.80.

Insider Buying and Selling at CME Group

In related news, COO Suzanne Sprague sold 1,500 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $256.83, for a total value of $385,245.00. Following the transaction, the chief operating officer now owns 8,036 shares of the company’s stock, valued at approximately $2,063,885.88. This trade represents a 15.73% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Hilda Harris Piell sold 3,984 shares of CME Group stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $250.47, for a total transaction of $997,872.48. Following the sale, the insider now owns 27,046 shares in the company, valued at approximately $6,774,211.62. The trade was a 12.84% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 23,134 shares of company stock worth $6,087,434 over the last three months. 0.30% of the stock is owned by insiders.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.